Palliative Care in a National Cancer Center

De Conno, 2001, Palliative care at the National Cancer Institute of Milan, Supportive Care in Cancer, 9, 141, 10.1007/s005200000219 De Conno, 1998, Eighteen years of home care, J Palliat Care, 14, 91, 10.1177/082585979801400319 De Conno, 1997, Video communication and palliative care at home, Euro J Palliat Med, 4, 174 De Conno, 1996, Effect of home care on the place of death of advanced cancer patients, Eur J Cancer, 32A, 1142, 10.1016/0959-8049(96)00036-6 Altman, 1991 Ripamonti, 2001, Clinical practice recommendations for the management of bowel obstruction in patients with end-stage cancer, Supportive Care in Cancer, 9, 223, 10.1007/s005200000198 Fainsinger, 2002, Hydration, 395 MacDonald, 2002, Ethical considerations in feeding or hydrating advanced cancer patients, 411 Bozzetti, 1996, Guidelines on artificial nutrition versus hydration in terminal cancer patients, Nutrition, 12, 163, 10.1016/S0899-9007(96)91120-X McCann, 1994, Comfort care for terminally Ill patients. The appropriate use of nutrition and hydration, JAMA, 272, 1263, 10.1001/jama.1994.03520160047041 Burge, 1993, Dehydration symptoms of palliative care cancer patients, J Pain Symptom Manage, 8, 454, 10.1016/0885-3924(93)90188-2 Sear, 1989, Studies on morphine disposition, Br J Anaesth, 62, 28, 10.1093/bja/62.1.28 Peterson, 1990, Plasma levels of morphine and morphine-glucuronides in the treatment of cancer pain, Eur J Clin Pharmacol, 38, 121, 10.1007/BF00265969 Faura, 1998, Systemic review of factors affecting the ratios of morphine and its major metabolites, Pain, 74, 43, 10.1016/S0304-3959(97)00142-5 Bruera, 1995, Changing pattern of agitated impaired mental status in patients with advanced cancer, J Pain Symptom Manage, 10, 287, 10.1016/0885-3924(95)00005-J Yan, 1991, Case report, J Palliat Care, 7, 40, 10.1177/082585979100700309 Cherny, 2001, Strategies to manage the adverse effects of oral morphine, J Clin Oncology, 19, 2542, 10.1200/JCO.2001.19.9.2542 Ripamonti, 1997, CNS adverse effects of opioids in cancer patients, CNS Drugs, 8, 21, 10.2165/00023210-199708010-00003 MacDonald, 1989, Hypernatremic dehydration in patients in a large hospital for the mentally handicapped, BMJ, 229, 1426, 10.1136/bmj.299.6713.1426 Sykes, 1993, Constipation and diarrhea, 299 Ripamonti, 2000, Role of octreotide, scopolamine butylbromide, and hydration in symptom control of patients with inoperable bowel obstruction and nasogastric tubes, J Pain Symptom Manage, 19, 23, 10.1016/S0885-3924(99)00147-5 Mercadante, 2000, Comparison of octreotide and hyoscine butylbromide in controlling gastrointestinal symptoms due to malignant inoperable bowel obstruction, Supportive Care Cancer, 8, 188, 10.1007/s005200050283 Monti, 1996, Use of red blood cell transfusions in terminally ill cancer patients admitted to a Palliative Care Unit, J Pain Symptom Manage, 12, 18, 10.1016/0885-3924(96)00044-9 Gleeson, 1995, Blood transfusion and its benefits in palliative care, Palliative Medicine, 9, 307, 10.1177/026921639500900405 Mozes, 1989, Evaluation of the appropriateness of blood and blood product transfusion using preset criteria, Transfusion, 29, 473, 10.1046/j.1537-2995.1989.29689318442.x Elwood, 1973, Evaluation of the clinical importance of anemia, Am J Clin Nutr, 26, 958, 10.1093/ajcn/26.9.958 Viteri, 1974, Anemia and physical work capacity, Clin Haematol, 3, 609 Wachtel, 1985, The use of transfusion in terminal cancer patients. Hospice versus conventional care setting, Transfusion, 25, 278, 10.1046/j.1537-2995.1985.25385219915.x Hawkins, 2000, The gastroduodenal toxicity of nonsteroidal anti-inflammatory drugs. A review of the literature, J Pain Symptom Manage, 20, 140, 10.1016/S0885-3924(00)00175-5 Wolfe, 1999, Gastrointestinal toxicity of nonsteroidal anti-inflammatory drugs, N Engl J Med, 340, 1888, 10.1056/NEJM199906173402407 Jenkins, 1999, Nonsteroidal anti-inflammatory drugs as adjuvant analgesics in cancer patients, Palliative Medicine, 13, 183, 10.1191/026921699666671383 Varga, 2000, Wolf in sheep's clothing?, Am J of Hospice & Palliative Care, 17, 280 Hanks, 1996, and the Expert Working Group of the European Association for Palliative Care. Morphine in cancer pain, Br Med J, 312, 823 Jenkins, 1988, Initial demographic, symptom and medication profiles in patients admitted to Continuing Palliative Care Units, J Pain Symptom Manage, 16, 163, 10.1016/S0885-3924(98)00068-2 Bruera, 1988, Palliative care in a cancer center, J Pain Symptom Manage, 5, 1, 10.1016/S0885-3924(05)80002-8 Benedetti, 2000, Criteria for opioid selection, J Pain Symptom Manage, 19, 410, 10.1016/S0885-3924(00)00152-4 World Health Organization, 1986 Hanks, 2001, Morphine and alternative opioids in cancer pain, Brit J Cancer, 84, 587, 10.1054/bjoc.2001.1680 Cherny, 1995, Opioid pharmacotherapy in the management of cancer pain. A survey of strategies used by pain physicians for the selection of analgesic drugs and routes of administration, Cancer, 76, 1283, 10.1002/1097-0142(19951001)76:7<1283::AID-CNCR2820760728>3.0.CO;2-0 Kalso, 1996, Epidural and subcutaneous morphine in the management of cancer pain, Pain, 67, 443, 10.1016/0304-3959(96)03161-2 Morley, 1993, Methadone in pain uncontrolled by morphine, The Lancet, 342, 1243, 10.1016/0140-6736(93)92228-L Galer, 1992, Individual variability in the response to different opioids. Report of five cases, Pain, 49, 87, 10.1016/0304-3959(92)90192-E Kloke, 2000, Toxicity and/or insufficient analgesia by opioid therapy, Support Care Cancer, 8, 479, 10.1007/s005200000153 Mercadante, 2001, Switching from morphine to methadone to improve analgesia and tolerability in cancer patients. A prospective study, J Clin Oncol, 19, 2898, 10.1200/JCO.2001.19.11.2898 Ripamonti, 1998, Pharmacological treatment of cancer pain, Tumori, 84, 289, 10.1177/030089169808400302 Davis, 2001, Methadone for relief of cancer pain, Supportive Care Cancer, 9, 73, 10.1007/s005200000180 De Conno, 1996, Clinical experience with oral methadone administration in the treatment of pain in 196 advanced cancer patients, J Clin Oncol, 14, 2836, 10.1200/JCO.1996.14.10.2836 Ventafridda, 1986, A randomized study on oral administration of morphine and methadone in the treatment of cancer pain, J Pain Symptom Manage, 1, 203, 10.1016/S0885-3924(86)80042-2 Ripamonti, 1998, Switching from morphine to oral methadone in treating cancer pain, J Clin Oncol, 16, 3216, 10.1200/JCO.1998.16.10.3216 Hogan, 1984, Epidural opiates and local anesthetics for the management of cancer pain, Pain, 46, 271, 10.1016/0304-3959(91)90110-J Mercadante, 2001, The use of corticosteroids in home palliative care, Support Care Cancer, 9, 386, 10.1007/s005200000218 Jatoi, 2002, Drug therapy for cancer-associated anorexia, 361 Tannok, 1989, Treatment of metastatic prostatic cancer with low dose prednisone, J Clin Oncol, 7, 590, 10.1200/JCO.1989.7.5.590 Watanabe, 1994, Corticosteroids as adjuvant analgesics, J Pain Symptom Manage, 9, 442, 10.1016/0885-3924(94)90200-3 Sorensen, 1994, Effect of high-dose dexamethasone in carcinomatous metastatic spinal cord compression treated with radiotherapy. A randomized trial, Eur J Cancer, 30A, 22, 10.1016/S0959-8049(05)80011-5 Ventafridda, 1987, Antidepressants increase bioavailability of morphine in cancer patients, Lancet, 1, 1204, 10.1016/S0140-6736(87)92172-6 Savard, 2001, Insomnia in the context of cancer, J Clin Oncol, 19, 895, 10.1200/JCO.2001.19.3.895 Bruera, 1996, Rapid discontinuation of hypnotics in terminal cancer patients, Annals of Oncology, 7, 855, 10.1093/oxfordjournals.annonc.a010766 Fulfaro, 1999, The role of bisphosphonates in the treatment of painful metastatic bone disease, Pain, 78, 157, 10.1016/S0304-3959(98)00135-3 Hillner, 2000, American Society of Clinical Oncology. Guidelines on the role of bisphosphonates in breast cancer, J Clin Oncol, 18, 1378, 10.1200/JCO.2000.18.6.1378 Groff, 2001, The role of disodium pamidronate in the management of malignant bone pain, Palliative Medicine, 15, 297, 10.1191/026921601678320287 Ripamonti, 2001, Strategies for the treatment of cancer pain in the New Millennium, Drugs, 61, 955, 10.2165/00003495-200161070-00005 De Conno, 1993, Paraplegia following celiac plexus block, Pain, 55, 383, 10.1016/0304-3959(93)90015-H Polati, 1993, Prospective randomized double-blind trial of neurolytic celiac plexus block in patients with pancreatic cancer, British J Surg, 85, 199, 10.1046/j.1365-2168.1998.00563.x Mercadante, 1993, Celiac plexus block versus analgesics in pancreatic cancer pain, Pain, 52, 187, 10.1016/0304-3959(93)90130-H